Patients aren’t joining clinical trials for the small reimbursements they may receive, expert says. “They know their volunteerism can advance science and help others.”
“If our objective [as an industry] is to develop trials with populations that reflect the real world, we must include everyone—it’s a moral and scientific imperative.”
With the COVID-19 pandemic far from being conquered across much of the globe but becoming somewhat more manageably endemic in areas, many clinical trials programs once entirely shuttered or retooled […]
“The Latinx population [by and large] still doesn’t understand what clinical trials are, and why they are important. We must do a better job at educating them.”
The way clinical trials are structured is “really prohibitive” for underserved populations, expert says.